Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
News about Enzoimmune might offset the lack of new revenue.?
Enzolytics created a new class of Preferred Stock, 10,000,000 shares of Series F. Institutional investors can buy up large amounts here.
Someone called the OTC and said that ENZC is ok until next quarter. Here is the link for what it is worth~
$ENZC Just got off the phone with OTC markets. They informed me that the company is current and is good until the next quarterly comes due. I explained the situation regarding the extension, they reviewed the ticket again and said “they are good” not sure if their is a delay. pic.twitter.com/FCKEuBDgSH
— Panther (@Pantherxiii) November 22, 2021
Reason given for the delay(they have to tell the truth here or they would be in deep trouble)~"The Company requires additional time to file the financial statement section of the quarterly Disclosure Statement due to the expansion of our international business activities."
Don't get shook. We are good.
We are good here~
$ENZC Just got off the phone with OTC markets. They informed me that the company is current and is good until the next quarterly comes due. I explained the situation regarding the extension, they reviewed the ticket again and said “they are good” not sure if their is a delay. pic.twitter.com/FCKEuBDgSH
— Panther (@Pantherxiii) November 22, 2021
Should start going up from here.
As expected, holding up good as we wait for financials.
Cute
Shorts will be hurting this week.
Go ENZC
The difference between Atomwise and Enzolytics is that Enzolytics has patents on immutable sites. Big difference.
Enzolytics move forward rapidly with a strategic focus on revenues as we introduce Enzolytics IPF Immune to the North American market.
#ENZC #REVENUE #immunemodulator
https://t.co/vNiypDAXAZ
Revenue!
ENZC
Mutat~Thank you for your insight. Now I beg you Mutat please stay on board here with us. Wish Otcshotcaller had stayed too.
GLTA
ENZC
Mutat~Do you or anyone have an inkling when this product will actually be on the market in the United States and Australia?
Shorts didn't expect a Wednesday PR. Charles is noted for his Tuesday and Thursday PR's. Love it!
$ENZC
As of 3/31/21, Australia's population was 25,704,340.
The combined licensed market areas of Australia and North American have a current population of over 604,053,000
https://t.co/Y7cq6lj2KR
#Revenue #ImmuneModulator #Enzolytics #Supplements https://t.co/n8xqBlSCWF
Immunomodulator market is huge and growing.
https://www.fortunebusinessinsights.com/immunomodulators-market-104692
This is not a new flavor of cotton candy. This an immunomodulator.
$enzc Some generic raw numbers
2% US (50B) markeshare for @enzoimmune immunomodulator
$1B revenue
Stock valuation of 10x 15x 20x = share price $3.57 $5.35 $7.14
2% of global market (200B) do a 4x those values
This doesn't include anything with mABs, just the immunomodulator
Why would Charles want to keep the price down? He himself owns a ton of shares.
When does the pump start?
Dr. Chandra, “Lots to achieve in 2021 as we march forward, fulfilling our milestones. #ENZC #ENZCstrong #animalmabs #immunemodulator #uplist #HIV #COVID #sciencewillwin”
I really enjoyed that testimony about your daughter going from negative positive attitude. As a preacher, I will use that testimony, Lord willing, in a message to multiply the blessings as others turn from negative outlook to positive.
Onward and upward.
Don't let the name of the degree fool you.
It doesn't say if it is a 2 year or 4 year degree or what university.
Here is what you can do with a Criminal justice degree~
Police Patrol Officer. Job Description. ...
Criminal Investigators & Special Agents. Job Description. ...
Private Detective or Investigator. ...
First-Line Police Supervisor. ...
Correctional Officer. ...
Probation and Parole Officers. ...
Postsecondary Criminal Justice & Law Enforcement Teachers.
Now makindatcash, Don't knock it. This guy has an earned 2 year degree in Automotive Technology where you learn how to change oil and tires on all kinds of vehicles. Lol What qualifications do you need today to throw your hat in the ring?
Says Gibson, "Man this is the best news since sliced bread, you must do your researching people."
Man this is the best news since sliced bread, you must do your researching people. https://t.co/xuqyJ1Igf9
— Derrick Gibson (@Gibson4NYS) November 10, 2021
This is the kind of support we need. He is very impressed with ENZC. GF just sent his extensive DD to Republican gubernatorial candidate Gibson. Gibson has 17.9 k followers on Twitter. He also has Facebook account. Looking forward to the podcast!
Derrick Gibson's (running for NYS governor)is highly interested in ENZC.
"Pay attention people theirs an ethical company coming your way, and it’s about saving lives not profits."
Pay attention people theirs an ethical company coming your way, and it’s about saving lives not profits. https://t.co/hX3hML92Y6
— Derrick Gibson (@Gibson4NYS) November 10, 2021
It would not strike me as a big surprise if ENZC has already secretly completed successful tests on some primates "in their own back yard" apart from any official trials. Thus, they would have gained the confidence needed for continuing forward. Just a thought.
"One must work; one must work, I have done what I could.” last words of Louis Pasteur, Pioneer in vaccines. $ ENZC is working overtime to change the world of medicine. Bacteria, yeast and mold infections have been virtually conquered. $ENZC will provide long awaited viral cures.
Maga~I noticed the exact same thing. Held at .1368. We more volume to overcome the mm's.
The big news is not today's PR. The big news is that Charles' muzzle finally came off.
More than a too kitClifton Roberts, Global Director, International Trade Group
Clifton Roberts, Global Director, International Trade Group
Oftentimes, when people think of AI, they think of a cold, logical, hyper-intelligent program with no empathy — not a mechanism to augment personalized human interaction. Yet this is what empathetic AI has been designed to do in the healthcare industry: perform complex tasks and analyses in order to free up time for health practitioners to interact directly with patients and form deep human connections. For years, Intel has been collaborating with healthcare experts and medical researchers to deploy empathetic AI capable of helping tackle many of the biggest healthcare challenges we face, including treating cancer and HIV.
As part of this effort, Intel in collaboration with Enzolytics, a developer of therapies for infectious diseases around the world, to publish a whitepaper, “Optimizing Empathetic AI to Cure Deadly Diseases.” This whitepaper outlines some of the recent medical advances Intel has been part of, including using deep learning to improve assessment of radiology images and subsequent diagnoses, to gain insight into tagging of protein sequences, to improve the accuracy and speed of screenings for cancer, and to map brain activity to develop advanced neurocognitive therapies and decode human thought.
The whitepaper also outlines how Enzolytics has used AI and advanced medical technologies in the search for an elusive HIV vaccine. By conducting an analysis with AI, researchers were able to validate research into “immutable” sites (sections of HIV’s RNA sequence that remain constant even as the virus mutates over time). With these immutable sites, doctors should be able to develop antibody treatments that attack these specific sites and neutralize (or at least lessen the impact of) the HIV virus. Though this is a long and complex process, AI has helped accelerate the work by providing high-speed analyses of large amounts of data.
For this kind of work to be possible on a broader scale, we believe specific investments are necessary to ensure the accuracy and efficacy of empathetic AI in healthcare. Here are some of our recommendations:
Deepening public-private partnerships: This past year has taught us how important effective partnerships between the U.S. government and private companies are when addressing public health issues and keeping the general population healthy. With the U.S. government currently purchasing half of all healthcare services in the country, we foresee public-private partnerships being critical to maximizing the good that empathetic AI can have in our society.
Implementing standards and frameworks: When you work with the vast amounts of data needed for AI, that data must be arranged into standardized sets and approached with standardized procedures to ensure accuracy and usability. That’s why we should foster secure data sharing between public and private entities, as well as create public databases of freely accessible and anonymized data for secure analysis without risk to patients or consumers.
Minimizing bias: Like all forms of AI, empathetic AI suffers when the programmers who develop them transfer their bias to the AI or the datasets on which the AI relies. We see the need for larger and more diverse datasets, as well as for more diversity in the field of AI development and research. With more perspectives at the table at every stage of the development process, AI will be less biased and more reliable, as will its datasets.
To read the rest of our recommendations, check out the full whitepaper, “Optimizing Empathetic AI to Cure Deadly Diseases.”
Published onSeptember 27, 2021AuthorClifton RobertsCategoriesArtificial Intelligence, Health Information TechnologyTagsempathetic AI, Enzolytics
Clifton Roberts
ABOUT CLIFTON ROBERTS
Wrong koogy
Achandler~ .30 sounds plausible, then next leg up from there.
Enzolytics + Intel AI + Samsung CDMO= $$$$
Enzolytics is the future of medicine.
Intel sought after Enzolytics
“Samsung Biologics WINS CDMO deal from Enzolytics for HIV, Covid-19 treatments”
Samsung CEO literally put his stamp on it
Jack, what do you think the PPS will be in let's say 6 to 8 months from now?
Hey DOGONE , Feb. 2020 was my starting point. Hadd 1,500,000. Sadly, I sold alot in the sub-pennied range when Harry was at the helm. Been adding since the RM. Have only 773,000 now. Averaging .07 currently. Hope it will be enough to retire. I'm ready!
MadIrish~ That was refreshing.
Agree raga